Dr. Koura is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3855 Health Sciences Dr
La Jolla, CA 92093Phone+1 858-657-7000Fax+1 858-822-6844
Education & Training
- Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2010 - 2013
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2006 - 2009
- Washington University in St. Louis School of MedicineClass of 2006
Certifications & Licensure
- CA State Medical License 2013 - 2026
- GA State Medical License 2011 - 2014
- HI State Medical License 2009 - 2012
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation Start of enrollment: 2019 Nov 26
Publications & Presentations
PubMed
- 2 citationsImpact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL.Ibrahim Aldoss, Gregory W Roloff, Rawan Faramand, Noam E Kopmar, Chenyu Lin
Blood Advances. 2024-12-10 - NCCN Guidelines® Insights: Survivorship, Version 2.2024.Tara Sanft, Andrew T Day, Mindy Goldman, Shannon Ansbaugh, Saro Armenian
Journal of the National Comprehensive Cancer Network. 2024-12-01 - 1 citationsOutcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL.Gregory W Roloff, Ibrahim Aldoss, Noam E Kopmar, Chenyu Lin, Simone E Dekker
Journal of Clinical Oncology. 2024-10-17
Other Languages
- Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: